SOGC Clinincal Practice Guidelines

No. 96, October 2000

The Reproductive Care of Women Living With Hepatitis C Infection

Principal Authors
Marc Boucher, MD, FRCSC, DABOG (MFM), Montreal QC
Andrée Gruslin, MD, RDMS, FRCSC, Ottawa ON

Working Group
Marc Boucher (Chair), MD, FRCSC, DABOG (MFM), Montreal QC*
Gilles Delage, MD, MSc, FRCPC, Ste-Anne-de-Bellevue, QC
Andrée Gruslin, MD, RDMS, FRCSC, Ottawa ON*
Tim McClemont, Executive Director, Hepatitis C Society of Canada, Toronto ON
Deborah M Money, MD, FRCSC,Vancouver BC*
Marc Steben, MD, CCFP FCFPC, Montreal QC*
Bernard Willems, MD, (Hepatol), Montreal QC
Tom Wong, MD, MPH, CCFP, Ottawa ON*
Lesley Zinman, patient representative, Iberville QC

Special Contributors
Lorna Grant, MD, FRCSC, Winnipeg MB
Lesley Smith, MD, MRCP(UK), FRCPC, Edmonton AB
Janet Smylie, MD, CCFP, Ottawa ON
Shimian Zou, MD, MPH, PhD, Ottawa ON

Medical Writers
Griffith Jones, MD, Ottawa ON
Liza Jones, MBBS, Ottawa ON

* Members of the Infectious Disease Committee of the SOGC
This document is sponsored by the Society of Obstetricians and Gynaecologists of Canada.

Funding for the development and distribution of these guidelines was provided by the Hepatitis C Division, Health Canada.

These guidelines reflect emerging clinical and scientific advances as of the date issued and are subject to change.The information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Local institutions can dictate amendments to these opinions.They should be well documented if modified at the local level. None of the contents may be reproduced in any form without prior written permission of SOGC.

I ABSTRACT

II. INTRODUCTION

III. EPIDEMIOLOGY

IV. VIROLOGY, CLINICAL MANIFESTATIONS, COURSE OF DISEASE